HAVCR2 and peripheral T-cell lymphoma, not otherwise specified: (1) A novel HAVCR2 compound heterozygous mutations in germline is identified in EBV-positive peripheral T-cell lymphoma(NOS) with down-regulated expression on TIM-3 signaling.